Purple Biotech Ltd (PPBT) — Strategic Asset Allocation Index
Purple Biotech Ltd (PPBT) has a Strategic Asset Allocation Index of 1.3% as of June 2023. Strategic assets (PP&E of ILA571.00K plus long-term investments of ILA-) total ILA571.00K, measured against net assets of ILA42.74 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See PPBT net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Purple Biotech Ltd Strategic Asset Allocation Index (2017–2022)
This chart shows how Purple Biotech Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 1.3%, representing strategic assets of ILA571.00K against net assets of ILA42.74 Million ILA. For live market cap and overall valuation, see Purple Biotech Ltd stock valuation.
Annual Strategic Asset Allocation Index for Purple Biotech Ltd (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Purple Biotech Ltd from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Purple Biotech Ltd (PPBT) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.4% | ILA682.00K | ILA682.00K | ILA0.00 | ILA47.10 Million | ▼ -0.2 pp |
| 2021 | 1.7% | ILA1.08 Million | ILA896.00K | ILA187.00K | ILA65.11 Million | ▲ +0.4 pp |
| 2020 | 1.2% | ILA968.00K | ILA968.00K | ILA0.00 | ILA79.75 Million | ▼ -1.0 pp |
| 2019 | 2.2% | ILA244.00K | ILA244.00K | ILA- | ILA10.86 Million | ▲ +1.9 pp |
| 2018 | 0.3% | ILA37.00K | ILA37.00K | ILA- | ILA11.00 Million | ▲ +0.0 pp |
| 2017 | 0.3% | ILA28.00K | ILA28.00K | ILA- | ILA8.59 Million | — |